NCT03525392 2023-12-12Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.IpsenPhase 1 Terminated14 enrolled 20 charts
NCT01132547 2015-07-02Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerUniversity of South FloridaPhase 3 Terminated22 enrolled 9 charts